Illumina Inc (ILMN) Growth Rates Comparisons to Laboratory Analytical Instruments Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Illumina Inc   (NASDAQ: ILMN)
 

Illumina Inc Growth Comparisons

Select each growth Category to receive further Information





ILMN Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 9.44 % 10.91 % 8.91 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) 6.23 % -3.61 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 4.88 % 4.93 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 2.28 % 2.54 % 2.03 % 2.61 %
Revenue 5 Year Average Growth 6.04 % 3.1 % 8.65 % 10.59 %


ILMN's Growth Comparisons in II. Quarter 2026




Comparing 9.44% year on year top-line growth in the second quarter 2026, Illumina Inc grew on the lower pace than the 10.91% rise in the Laboratory Analytical Instruments industry, but beating the 8.91% growth in the Healthcare sector. Comparing the second quarter sales, Illumina Inc was trailing overall market not just the Laboratory Analytical Instruments industry.

Comparing the company's Revenue to the first quarter results, sales were higher by 6.23% . On the yearly basis, average annual sales growth for Illumina Inc is 6.04%, while S & P 500's including only Businesses with the second quarter 2026 earnings, average annual sales growth is 10.59% over the past five years.

ILMN Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Product
-
-
Service
-
-
Sequencing
110.8 %
105.93 %
Microarray
132.18 %
110.42 %
Consumables
103.33 %
106.9 %
Instruments
147.52 %
108.33 %
United States and Canada
-
110.68 %
EMEA
-
-
China
-
-
Asia Pacific
-
-
Core Illumina
112.56 %
106.32 %
Total
9.44 %
6.23 %


Growth Rates of ILMN's Income in the second quarter 2026


ILMN Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) 14.49 % 67.67 % 4.62 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) 17.22 % -28.55 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) -31.71 % 9.27 % 30.73 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) 3.64 % 10.32 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change - -6.57 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) -11.91 % - -25.98 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) 54.48 % - -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) -34.37 % - 2.68 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) -3.28 % -7.36 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - -16.43 % 0.17 % -28.52 %

ILMN Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) -11.91 % -37.36 % -26.26 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) 54.48 % -93.87 % -0.77 % 27.07 %
Y / Y Net Income Change (Q2 TTM) -34.37 % - 15.51 % 57.33 %
Sequential Net Income Change (Q2 TTM) -3.28 % -2.34 % -6.72 % 18.65 %
Net Income 5 Year Avg. Growth - -16.48 % 9.21 % 22.96 %

ILMN's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) -8.05 % - -25.98 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) 55.68 % - -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) -32.07 % - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) -2.18 % -56.1 % - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 4.07 % -21.88 % 0.17 % -28.52 %



ILMN EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) -9.4 % -38.22 % -26.26 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) 55.17 % -93.96 % -0.77 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) -2.55 % -56.06 % - 4.93 %
EPS Net 5 Year Avg. Change 4.14 % -16.48 % 9.21 % 22.96 %



Facing -9.4% year on year income per share decrease in the second quarter, to $ 1.35, Illumina Inc reported smaller declines than the Laboratory Analytical Instruments industry with -38.22%, and less than -26.26% slide in the Healthcare sector. Slow second quarter 2026 income per share in Laboratory Analytical Instruments industry and Healthcare sector, were portrayed in Illumina Inc 's results, which underperformed overall market.

The bottom-line grew by 55.17% from the first quarter. Average yearly income per share growth for Illumina Inc is 4.14%, while S & P 500's average annual income per share increase is 22.96% over the five years, including only Businesses with the second quarter 2026 earnings reports.

ILMN Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) -21.08 % -38.71 % 48.49 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) -35.86 % -56.03 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) -9.7 % -16.79 % 18.61 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) -4.41 % -7.79 % 5.39 % 15.75 %
Free Cash Flow 5 Year Avg. Change 0.88 % -2.7 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) 1007.14 % - - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - -92.95 % - 152.64 %
Net Cash Flow 5 Year Avg. Change - 16.21 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 33.33 % -5.56 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) 5.26 % -18.49 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) 33.33 % -5.65 % 7.87 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) 6.49 % -1.57 % 1.6 % 23.05 %
Capital Expenditures 5 Year Avg. Change -4.77 % 4.39 % 9.12 % 14.73 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.